175 related articles for article (PubMed ID: 35449018)
1. Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.
Luijten JCHBM; Vissers PAJ; Brom L; de Bièvre M; Buijsen J; Rozema T; Mohammad NH; van Duijvendijk P; Kouwenhoven EA; Eshuis WJ; Rosman C; Siersema PD; van Laarhoven HWM; Verhoeven RHA; Nieuwenhuijzen GAP; Westerman MJ
BMC Health Serv Res; 2022 Apr; 22(1):527. PubMed ID: 35449018
[TBL] [Abstract][Full Text] [Related]
2. Treatment decision-making during outpatient clinic visit of patients with esophagogastric cancer. The perspectives of clinicians and patients, a mixed method, multiple case study.
Luijten JCHBM; Brom L; Vissers PAJ; van de Wouw YAJ; Warmerdam FARM; Heisterkamp J; Mook S; Oulad Hadj J; van Det MJ; Timmermans L; Hulshof MCCM; van Laarhoven HWM; Rosman C; Siersema PD; Westerman MJ; Verhoeven RHA; Nieuwenhuijzen GAP
Cancer Med; 2022 Jun; 11(12):2427-2444. PubMed ID: 35166037
[TBL] [Abstract][Full Text] [Related]
3. Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
Luijten JCHBM; Vissers PAJ; Geerts J; Lemmens VEP; van Hillegersberg R; Beerepoot L; Walraven JEW; Curvers W; Voncken FEM; van der Sangen M; Verhoeven RHA; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2023 Sep; 49(9):106880. PubMed ID: 37055281
[TBL] [Abstract][Full Text] [Related]
4. [Hospital of diagnosis influences the probability of receiving curative treatment for oesophageal and gastric cancer].
van Putten M; Verhoeven RHA; Koëter M; van Laarhoven HWM; van Sandick JW; Plukker JTM; Siersema PD; Hulshof MCCM; Wijnhoven BPL; Lemmens VEPP; Nieuwenhuijzen GAP
Ned Tijdschr Geneeskd; 2018; 162():D1970. PubMed ID: 29600921
[TBL] [Abstract][Full Text] [Related]
5. Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancer.
Luijten JCHBM; Vissers PAJ; Lingsma H; van Leeuwen N; Rozema T; Siersema PD; Rosman C; van Laarhoven HWM; Lemmens VEP; Nieuwenhuijzen GAP; Verhoeven RHA
Cancer Epidemiol; 2021 Apr; 71(Pt A):101897. PubMed ID: 33484974
[TBL] [Abstract][Full Text] [Related]
6. Team dynamics and clinician's experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study.
Luijten JCHBM; Westerman MJ; Nieuwenhuijzen GAP; Walraven JEW; Sosef MN; Beerepoot LV; van Hillegersberg R; Muller K; Hoekstra R; Bergman JJGHM; Siersema PD; van Laarhoven HWM; Rosman C; Brom L; Vissers PAJ; Verhoeven RHA
Front Oncol; 2022; 12():1003506. PubMed ID: 36330470
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a regional video multidisciplinary team meeting is associated with an improved prognosis for patients with oesophageal cancer A mixed methods approach.
Luijten JCHBM; Haagsman VC; Luyer MDP; Vissers PAJ; Nederend J; Huysentruyt C; Creemers GJ; Curvers W; van der Sangen M; Heesakkers FBM; Schrauwen RWM; Jürgens MC; Buster EHCJ; Vincent J; Kneppelhout JK; Verhoeven RHA; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2021 Dec; 47(12):3088-3096. PubMed ID: 33926781
[TBL] [Abstract][Full Text] [Related]
8. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
9. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Wijnhoven BP; Nieuwenhuijzen GA
Eur J Surg Oncol; 2014 Oct; 40(10):1338-45. PubMed ID: 24484779
[TBL] [Abstract][Full Text] [Related]
10. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
Walsh SLF; Wells AU; Desai SR; Poletti V; Piciucchi S; Dubini A; Nunes H; Valeyre D; Brillet PY; Kambouchner M; Morais A; Pereira JM; Moura CS; Grutters JC; van den Heuvel DA; van Es HW; van Oosterhout MF; Seldenrijk CA; Bendstrup E; Rasmussen F; Madsen LB; Gooptu B; Pomplun S; Taniguchi H; Fukuoka J; Johkoh T; Nicholson AG; Sayer C; Edmunds L; Jacob J; Kokosi MA; Myers JL; Flaherty KR; Hansell DM
Lancet Respir Med; 2016 Jul; 4(7):557-565. PubMed ID: 27180021
[TBL] [Abstract][Full Text] [Related]
11. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.
van Putten M; Verhoeven RH; van Sandick JW; Plukker JT; Lemmens VE; Wijnhoven BP; Nieuwenhuijzen GA
Br J Surg; 2016 Feb; 103(3):233-41. PubMed ID: 26621158
[TBL] [Abstract][Full Text] [Related]
12. Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival.
van Hoeve JC; Verhoeven RHA; Nagengast WB; Oppedijk V; Lynch MG; van Rooijen JM; Veldhuis P; Siesling S; Kouwenhoven EA
Eur J Surg Oncol; 2023 Jan; 49(1):106-112. PubMed ID: 35963750
[TBL] [Abstract][Full Text] [Related]
13. Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
Messager M; de Steur W; Boelens PG; Jensen LS; Mariette C; Reynolds JV; Osorio J; Pera M; Johansson J; Kołodziejczyk P; Roviello F; De Manzoni G; Mönig SP; Allum WH;
Eur J Surg Oncol; 2016 Sep; 42(9):1432-47. PubMed ID: 26898839
[TBL] [Abstract][Full Text] [Related]
14. Geographic impact on access to care and survival for non-curative esophagogastric cancer: a population-based study.
Yee EK; Coburn NG; Zuk V; Davis LE; Mahar AL; Liu Y; Gupta V; Darling G; Hallet J
Gastric Cancer; 2021 Jul; 24(4):790-799. PubMed ID: 33550518
[TBL] [Abstract][Full Text] [Related]
15. [Completeness and quality of multidisciplinary team meetings: the example of prostate cancer in the Mid-Pyrenees region].
Huo Yung Kai S; Delpierre C; Gaudin C; Goddard J; Daubisse-Marliac L; Soulié M; Bauvin E; Grosclaude P
Prog Urol; 2011 Nov; 21(12):879-86. PubMed ID: 22035915
[TBL] [Abstract][Full Text] [Related]
16. The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival.
Vissers PAJ; Luijten JCHBM; Lemmens VEPP; van Laarhoven HWM; Slingerland M; Wijnhoven BPL; Rosman C; Mook S; Heisterkamp J; Hendriksen EM; Gisbertz SS; Nieuwenhuijzen GAP; Verhoeven RHA
Eur J Surg Oncol; 2023 Oct; 49(10):107019. PubMed ID: 37659340
[TBL] [Abstract][Full Text] [Related]
17. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
Hocazade C; Özdemir N; Yazici O; Bozkaya Y; Yazılıtaş D; Toptaş Ş; Zengin N; Deren T
Ann Nucl Med; 2015 Aug; 29(7):621-6. PubMed ID: 26008856
[TBL] [Abstract][Full Text] [Related]
18. Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study.
Vermeulen BD; Bruggeman L; Bac DJ; Schrauwen RWM; Epping LSM; Scheffer RCH; Tan ACITL; Groenen MJM; Verhoeven RHA; Siersema PD
Acta Oncol; 2020 Apr; 59(4):410-416. PubMed ID: 32067535
[No Abstract] [Full Text] [Related]
19. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
Kroese TE; van Rossum PSN; Nilsson M; Lordick F; Smyth EC; Rosati R; Nafteux P; D'Ugo D; Chaudry MA; Polkowkski W; Roviello F; Gockel I; Kolodziejczyk P; Haustermans K; Guckenberger M; Nordsmark M; Hawkins MA; Cervantes A; Fleitas T; van Cutsem E; Moehler M; Wagner AD; van Laarhoven HWM; van Hillegersberg R;
Eur J Surg Oncol; 2023 Jan; 49(1):21-28. PubMed ID: 36184420
[TBL] [Abstract][Full Text] [Related]
20. Third international conference of the European Union Network of Excellence on gastric and esophagogastric junction cancer, Cologne, Germany, June 2012.
Moenig SP; Meyer HJ; Allum WH; De Manzoni G; Garofalo A; Baltin CT; Fetzner UK; Hoelscher AH
Gastric Cancer; 2015 Jan; 18(1):193-9. PubMed ID: 24522716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
